规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Heat shock protein 90 (Hsp90) is a molecular chaperone protein that stabilizes client oncogenic proteins in breast cancer cells. PU-H71 is a novel Hsp90 inhibitor with an IC50 value of 51nM. The treatment with PU-H71 at a dosage of 1µM resulted in significant cell death in triple-negative breast cancer (TNBC) cell lines MDA-MB-468 (80%), MDA-MB-231 (65%), and HCC-1806 (80%). The inhibition of Hsp90 by PU-H71 (10–1000nM) induced a concentration-dependent inactivation or degradation of tumor driving molecules, including epidermal growth factor receptor, insulin-like growth factor receptor, HER3, and c-Kit. PU-H71 (10–1000nM) also downregulated the proteins related to G2-M progression, such as cyclin-dependent kinase 1 and checkpoint kinase 1. The treatment of MDA-MB-468 cells with 0.25, 0.5, and 1μM PU-H71 for 24 h increased the percentage of cells in G2-M phase to 30%, 44%, and 69%, respectively. PU-H71 at 250–1000nM induced apoptosis in TNBC cells by inactivating and downregulating Bcl-xL and Akt. The treatment of MDA-MB-231 cells with 0.5 and 1μM PU-H71 for 24 h reduced the NF-κB activity by 84% and 90%, respectively. In the MDA-MB-231 xenograft mouse model, PU-H71 (75 mg/kg on an alternate day schedule) completely inhibited tumor growth after 37 days of treatment. In the fast growing HCC-1806 tumors, six doses of PU-H71 (75 mg/kg on an alternate day schedule) over a 12 days resulted in an 87% regression in tumor volume. |
作用机制 | PU-H71 is a potent inhibitor of Hsp90 both in vitro and in vivo. When Hsp90 is inactivated, many TNBC oncoproteins that form a complex with PU-H71-bound Hsp90 become destabilized and subsequently degraded. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
H69AR cells | Function assay | 96 h | Inhibition of HSP90-mediated antiapoptotic activity in human H69AR cells assessed as induction of cell growth arrest at 10 after 96 hrs by propidium iodide staining-based flow cytometry | 17603540 | |
MCF7 cells | Function assay | 24 h | Inhibition of Hsp90 in human MCF7 cells assessed as Her2 level after 24 hrs by Western blot, IC50=0.06 μM | 18571929 | |
MDA-MB-468 cells | Function assay | Inhibitory activity against Hsp90 in human breast cancer MDA-MB-468 cell line, EC50=0.0102 μM | 16392823 | ||
MRC5 cells | Cytotoxicity assay | Cytotoxicity against normal lung fibroblast MRC5 cell line, IC50=1 μM | 16392823 | ||
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.95mL 0.39mL 0.20mL |
9.76mL 1.95mL 0.98mL |
19.52mL 3.90mL 1.95mL |
CAS号 | 873436-91-0 |
分子式 | C18H21IN6O2S |
分子量 | 512.37 |
SMILES Code | NC1=C2N=C(SC3=C(I)C=C(OCO4)C4=C3)N(CCCNC(C)C)C2=NC=N1 |
MDL No. | MFCD18251588 |
别名 | Pu-h 71; NSC 750424; PU-H71 |
运输 | 蓝冰 |
InChI Key | SUPVGFZUWFMATN-UHFFFAOYSA-N |
Pubchem ID | 9549213 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|